Stanley Sy, CEO and director of Sanomics, demonstrates an experiment at the Hong Kong Science Park in Sha Tin. Photo: Dickson Lee
Hong Kong could become a hub for genetics-based drugs discovery. Just one hitch – would Beijing stand in way?
- Beijing bans export of human genetics data, citing national security concerns
-
Without mainland data, envisioned database would be of limited use
Topic |
Pharmaceuticals
Stanley Sy, CEO and director of Sanomics, demonstrates an experiment at the Hong Kong Science Park in Sha Tin. Photo: Dickson Lee